Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammation. (Q45991780)
Jump to navigation
Jump to search
scientific article published on 28 May 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammation. |
scientific article published on 28 May 2009 |
Statements
1 reference
Novel tight-binding inhibitory factor-kappaB kinase (IKK-2) inhibitors demonstrate target-specific anti-inflammatory activities in cellular assays and following oral and local delivery in an in vivo model of airway inflammation. (English)
1 reference
Cynthia D Sommers
1 reference
Janice M Thompson
1 reference
Julia A Guzova
1 reference
Sheri L Bonar
1 reference
Randall K Rader
1 reference
Sumathy Mathialagan
1 reference
Neetu Venkatraman
1 reference
Vicky Walker Holway
1 reference
Larry E Kahn
1 reference
George Hu
1 reference
Debra S Garner
1 reference
Horng-Chih Huang
1 reference
Po-Chang Chiang
1 reference
John F Schindler
1 reference
Yiding Hu
1 reference
Debra M Meyer
1 reference
Nandini N Kishore
1 reference
28 May 2009
1 reference
330
1 reference
2
1 reference
377-388
1 reference
Identifiers
1 reference
1 reference